UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stock Holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 14.1% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 299,156 shares of the company's stock after purchasing an additional 36,990 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.11% of Ryan Specialty worth $19,194,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Voloridge Investment Management LLC increased its holdings in shares of Ryan Specialty by 4.7% in the fourth quarter. Voloridge Investment Management LLC now owns 609,995 shares of the company's stock worth $39,137,000 after purchasing an additional 27,657 shares during the last quarter. Sone Capital Management LLC bought a new stake in Ryan Specialty during the fourth quarter worth approximately $8,303,000. Waters Parkerson & CO. LLC increased its stake in Ryan Specialty by 9.9% during the fourth quarter. Waters Parkerson & CO. LLC now owns 358,710 shares of the company's stock worth $23,015,000 after acquiring an additional 32,380 shares during the last quarter. Two Sigma Advisers LP increased its stake in Ryan Specialty by 693.3% during the fourth quarter. Two Sigma Advisers LP now owns 35,700 shares of the company's stock worth $2,291,000 after acquiring an additional 31,200 shares during the last quarter. Finally, Two Sigma Investments LP increased its stake in Ryan Specialty by 114.9% during the fourth quarter. Two Sigma Investments LP now owns 204,817 shares of the company's stock worth $13,141,000 after acquiring an additional 109,522 shares during the last quarter. 84.82% of the stock is owned by institutional investors.

Ryan Specialty Stock Up 2.4%

Ryan Specialty stock traded up $1.67 during midday trading on Friday, hitting $71.61. 704,225 shares of the company's stock were exchanged, compared to its average volume of 987,095. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.01 and a current ratio of 1.01. Ryan Specialty Holdings, Inc. has a 12 month low of $52.34 and a 12 month high of $77.16. The firm has a 50-day moving average of $69.90 and a two-hundred day moving average of $68.75. The company has a market cap of $18.79 billion, a PE ratio of 103.78, a P/E/G ratio of 1.19 and a beta of 0.68.

Ryan Specialty (NYSE:RYAN - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.39. The company had revenue of $690.17 million for the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm's quarterly revenue was up 25.0% on a year-over-year basis. During the same period in the prior year, the business earned $0.35 EPS. As a group, analysts expect that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Tuesday, May 13th were paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's dividend payout ratio (DPR) is presently 141.18%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on RYAN. TD Cowen began coverage on Ryan Specialty in a research note on Thursday, April 10th. They set a "buy" rating and a $89.00 price objective on the stock. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 9th. Morgan Stanley boosted their price objective on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research note on Monday, May 19th. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and upped their target price for the company from $74.00 to $81.00 in a research note on Tuesday, May 13th. Finally, Wells Fargo & Company reduced their price target on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a report on Thursday, April 10th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Ryan Specialty presently has a consensus rating of "Moderate Buy" and an average target price of $75.58.

Insider Buying and Selling

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 52.21% of the stock is owned by company insiders.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.